Fenwick represented Wheels Labs on the deal. Wheels Labs, a last-mile, shared electric mobility platform using proprietary vehicles with integrated helmet technology, announced its acquisition by Helbiz,...
You must be a Standard 1 Year member to access this content.
Fenwick represented Yuga Labs on the deal. Yuga Labs, a web3 company and home of the Bored Ape Yacht Club, announced its acquisitions of WENEW, a developer...
You must be a Standard 1 Year member to access this content.
Fenwick represented Ordergroove on the deal. Ordergroove, a provider of subscriptions for retailers and direct-to-consumer brands like L’Oréal, Bonafide, The Honest Company, La Colombe and PetSmart,...
You must be a Standard 1 Year member to access this content.
Fenwick advised Pharmakon on the deal while Akin Gump advised Pharmakon Advisors. Pharmakon, an investor in non-dilutive debt for the life sciences industry and the investment...
You must be a Standard 1 Year member to access this content.
Fenwick represented Royalty Pharma on the deal. Royalty Pharma (Nasdaq: RPRX), a buyer of biopharmaceutical royalties and funder of innovation across the biopharmaceutical industry, announced the...
You must be a Standard 1 Year member to access this content.
Fenwick represented Versa Networks on the deal. Versa Networks, a recognized leader of single-vendor Secure Access Service Edge (SASE) platforms, announced its $120 million financing. The round...
You must be a Standard 1 Year member to access this content.
Fenwick represented Collide Capital on the deal. Collide Capital, one of the largest Black-owned first-time funds, announced the launch of its $66 million inaugural fund. Collide Capital...
You must be a Standard 1 Year member to access this content.
Fenwick represented UserTesting, Kirkland & Ellis represented Thoma Bravo, Goodwin Procter advised Sunstone Partners on the deal. UserTesting, a video-based human insight company, announced its acquisition by...
You must be a Standard 1 Year member to access this content.
Fenwick represented Landis on the deal. Landis, a financial education and coaching platform making the path to homeownership more accessible, announced its $40 million Series B financing....
You must be a Standard 1 Year member to access this content.
Covington advised Insmed Incorporated on the deal while Fenwick represented Pharmakon. Walder Wyss advised the funds managed by Pharmakon Advisors, LP, BioPharma Credit and OrbiMed. Akin...
You must be a Standard 1 Year member to access this content.
Fenwick represented TripActions on the deal. TripActions, a travel and spend management platform, announced its $154 million Series G at a valuation to $9.2 billion, including new...
You must be a Standard 1 Year member to access this content.
Fenwick represents Royalty Pharma on the deal. Royalty Pharma (Nasdaq: RPRX), a buyer of biopharmaceutical royalties and funder of innovation across the biopharmaceutical industry, announced IP diligence...
You must be a Standard 1 Year member to access this content.
